These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 39002870)

  • 1. Cancer-associated fibroblasts mediate resistance to anti-EGFR therapies in cancer.
    Dai S; Liu Y; Liu Z; Li R; Luo F; Li Y; Dai L; Peng X
    Pharmacol Res; 2024 Aug; 206():107304. PubMed ID: 39002870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of drug resistance for EGFR-TKIs in lung cancer via multicellular lung-on-a-chip.
    Tan J; Zhu L; Shi J; Zhang J; Kuang J; Guo Q; Zhu X; Chen Y; Zhou C; Gao X
    Eur J Pharm Sci; 2024 Aug; 199():106805. PubMed ID: 38763450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies.
    Apicella M; Giannoni E; Fiore S; Ferrari KJ; Fernández-Pérez D; Isella C; Granchi C; Minutolo F; Sottile A; Comoglio PM; Medico E; Pietrantonio F; Volante M; Pasini D; Chiarugi P; Giordano S; Corso S
    Cell Metab; 2018 Dec; 28(6):848-865.e6. PubMed ID: 30174307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine.
    Kanzaki R; Pietras K
    Cancer Sci; 2020 Aug; 111(8):2708-2717. PubMed ID: 32573845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies.
    Zhou J; Ji Q; Li Q
    J Exp Clin Cancer Res; 2021 Oct; 40(1):328. PubMed ID: 34663410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutation.
    Yoshida T; Ishii G; Goto K; Neri S; Hashimoto H; Yoh K; Niho S; Umemura S; Matsumoto S; Ohmatsu H; Iida S; Niimi A; Nagai K; Ohe Y; Ochiai A
    Clin Cancer Res; 2015 Feb; 21(3):642-51. PubMed ID: 25388165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer associated-fibroblast-derived exosomes in cancer progression.
    Li C; Teixeira AF; Zhu HJ; Ten Dijke P
    Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A centralized communication network: Recent insights into the role of the cancer associated fibroblast in the development of drug resistance in tumors.
    Leask A
    Semin Cell Dev Biol; 2020 May; 101():111-114. PubMed ID: 31708414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretion of high amounts of hepatocyte growth factor is a characteristic feature of cancer-associated fibroblasts with EGFR-TKI resistance-promoting phenotype: A study of 18 cases of cancer-associated fibroblasts.
    Suzuki E; Yamazaki S; Naito T; Hashimoto H; Okubo S; Udagawa H; Goto K; Tsuboi M; Ochiai A; Ishii G
    Pathol Int; 2019 Aug; 69(8):472-480. PubMed ID: 31339210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNAs Delivery for Cancer-associated Fibroblasts' Activation and Drug Resistance in Cancer Microenvironment.
    Anajafi S; Paryan M; Khoshnazar A; Soleimani M; Mohammadi-Yeganeh S
    Endocr Metab Immune Disord Drug Targets; 2024; 24(3):333-347. PubMed ID: 37612874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of annexin A2 and cancer-associated fibroblasts in advanced non-small cell lung cancer: Implication in epithelial-mesenchymal transition and gefitinib resistance.
    Ibrahim FM; Helal DS; Ali DA; Abd-Ellatif RN; Elkady AM; Sharshar R; Gharib F; Abo Elnasr M; El-Guindy DM
    Pathol Res Pract; 2023 Jan; 241():154293. PubMed ID: 36586309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer associated fibroblast mediated chemoresistance: A paradigm shift in understanding the mechanism of tumor progression.
    Jena BC; Das CK; Bharadwaj D; Mandal M
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188416. PubMed ID: 32822826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active autophagy in cancer-associated fibroblasts: Recent advances in understanding the novel mechanism of tumor progression and therapeutic response.
    Jena BC; Rout L; Dey A; Mandal M
    J Cell Physiol; 2021 Nov; 236(11):7887-7902. PubMed ID: 34008184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance.
    Fiori ME; Di Franco S; Villanova L; Bianca P; Stassi G; De Maria R
    Mol Cancer; 2019 Mar; 18(1):70. PubMed ID: 30927908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity and Biology of Cancer-Associated Fibroblasts.
    Biffi G; Tuveson DA
    Physiol Rev; 2021 Jan; 101(1):147-176. PubMed ID: 32466724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma.
    Zhang H; Xie C; Yue J; Jiang Z; Zhou R; Xie R; Wang Y; Wu S
    Mol Carcinog; 2017 Mar; 56(3):1150-1163. PubMed ID: 27769097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):340-351. PubMed ID: 32496971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
    Erin N; Grahovac J; Brozovic A; Efferth T
    Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Versatility of Cancer Associated Fibroblasts: Commendable Targets for Anti-tumor Therapy.
    Khan GJ; Sun L; Khan S; Yuan S; Nongyue H
    Curr Drug Targets; 2018; 19(13):1573-1588. PubMed ID: 29468965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.